Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance

Clinical trial NCT06740916 · RECRUITING

Trial details

NCT number: NCT06740916
Sponsor: Siriraj Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloproliferative Neoplasms (MPN)

Start date: 2024-12-12
Primary completion: 2027-12-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.